Potential coronavirus treatment granted rare disease status

Dh logo

Local coronavirus coverage

Southwest Life

Potential coronavirus treatment granted rare disease status

Gilead Sciences CEO Daniel O’Day speaks at a meeting with President Donald Trump, members of the Coronavirus Task Force, and pharmaceutical executives in the Cabinet Room of the White House in Washington. Gilead, the pharmaceutical giant that makes remdesivir, a promising coronavirus drug, has registered it as a rare disease treatment with U.S. regulators on Monday, March 23, 2020, a status that can potentially be worth millions in tax breaks and competition-free sales.

Potential coronavirus treatment granted rare disease status

Gilead Sciences CEO Daniel O’Day speaks at a meeting with President Donald Trump, members of the Coronavirus Task Force, and pharmaceutical executives in the Cabinet Room of the White House in Washington. Gilead, the pharmaceutical giant that makes remdesivir, a promising coronavirus drug, has registered it as a rare disease treatment with U.S. regulators on Monday, March 23, 2020, a status that can potentially be worth millions in tax breaks and competition-free sales.
Listen
Loading the English audio player...
click here to add your event
Area Events